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Potential Regulation of Breast Cancer Invasion by Thymidine Kinase 1

Eliza E. Bitter, Rachel M. Morris, Toni O. Mortimer, Kai Barlow, Abigail Schekall, Michelle H. Townsend, Jonathan Skidmore, Brett E. Pickett, and Kim L. O’Neill
Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, 84602 USA
ABSTRACT

Breast cancer is the most common cancer in women and is largely
treatable within the early stages of the disease. However, patient
mortality drastically declines as the tumor begins to invade other
tissues and metastasize, making aggressive phenotypes especially
problematic to treat. Such treatment typically requires an aggressive
and decisive multidisciplinary approach. The recent expansion of
immunotherapy as a viable treatment option has greatly improved
treatment outcomes, especially with aggressive breast cancer
phenotypes. Thymidine kinase 1 (TK1) is a DNA salvage pathway
enzyme that is highly expressed during S phase and involved in cell
cycle repair. Past studies indicated that TK1 is secreted into the serum
of cancer patients and that its upregulation is an early event in
tumorigenesis, thus suggesting that TK1 upregulation may have
potential importance in tumor progression.
This study’s objective was to further elucidate TK1’s role in tumor
progression and metastasis of breast cancer specifically. We
hypothesized that TK1 overexpression in breast cancer may affect
invasion. To investigate this, TK1 mRNA transcript levels were analyzed
between normal and BRCA patient tissue samples. The wild-type breast
cancer cell line HCC 1806 was used, as well as a TK1 knockdown (L133)
which was produced using CRISPR-Cas9. Successful TK1 knockdown was
verified through western blot and qPCR. Bioinformatics was also
performed to analyze the relationship between our breast cancer cell
lines and various cell adhesion factors. The cell lines HCC 1806 and L133
were then tested with an invasive scratch assay. Additional western
blots were run to further investigate the potential relationship TK1 may
have with other cell cycle checkpoint proteins. Results showed that TK1
mRNA transcript levels are higher in BRCA tissues compared to normal
controls. Western blot and qPCR indicated that TK1 was successfully
knocked down in L133 cells. Bioinformatic differential gene analysis
revealed several correlations with cell adhesion factors, with
contrasting correlations when compared between the HCC 1806 and
L133 cell lines. The invasive scratch assay results indicated that the TK1
knockdown L133 cells were less invasive than HCC 1806 cells.
In conclusion, results verified that TK1 is highly expressed in breast
cancer and that it may help tumor invasion by influencing cell adhesion
factors. Further investigation to understand TK1’s potential interactions
with important cell adhesion factors, such as FHL1 or GAS6, may help
elucidate other therapeutic targets for preventing disease progression.

METHODS
• qPCR
•Western blot
•CRISPR-Cas9
•Bioinformatic Differential Gene Analysis
•Cell Migration Assay
•Invasive Scratch Assay

RESULTS

CONCLUSIONS
Figure 2: Bioinformatic differential gene analysis between HCC 1806 and L133 cells.

Figure 1: CRISPR-Cas9 knockdown. I. Western blot detection for TK1 and loading control (GAPDH) in HCC 1806 and L133
cell lysate. A student’s t-test was used to test if there was a difference in mean relative expression for TK1 in HCC 1806
and L133 cells. II. Fold change was calculated for TK1 from in HCC 1806 and L133 cells. L133 cells had a lower fold change
for TK1 when compared to HCC 1806 cells (student’s t-test p< 0.01).

RNA-seq bioinformatic analysis shows that there is differential
gene expression (DEG) between HCC 1806 and L133 cells. Of the
DEGs, genes involved in cell adhesion and cell cycle were
apparent. In addition, cell adhesion was a significant term
uncovered through GO enrichment analysis. Invasive scratch
assay results show that TK1 knockdown L133 cells are less
invasive than HCC 1806 cells. Western blot analysis between
HCC 1806 and L133 cells of factors linked to invasion point to
potential interactions by which TK1 is affecting invasion. Our
results suggest that TK1 upregulation in breast cancer cells may
influence breast cancer invasion by modifying cycle cell
proliferation and cell adhesion factor’s expression. Analysis of
TK1’s potential interaction may provide insights on breast cancer
progression.

FUTURE DIRECTIONS
1) Determine protein regulation at the gene level of factors
related to invasion through qPCR.
2) Perform flow cytometry/Western Blot for additional cell
adhesion factors and compare levels between HCC 1806 and
L133 cells
3) Perform co-IP experiments to elucidate the mechanism by
which TK1 is affecting invasion.
4) Identify other potential therapeutic targets
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